MedTrace Logo

Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia

NCT00719537 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-04-17

Study results available
· View outcomes & findings →

Summary

This study investigates whether low dose aspirin combined with progesterone will decrease the risk of preeclampsia in pregnant women with a history of preeclampsia in a previous pregnancy.

Conditions

Interventions

DRUG

Aspirin

Aspirin 81 mg once a day

DRUG

Placebo Oral Tablet

Placebo 1 tab Daily

DRUG

Progesterone

Oral Progesterone 200 mg Twice Daily

Sponsors & Collaborators

  • John Uckele

    lead OTHER

Principal Investigators

  • John E Uckele, MD · William Beaumont Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00719537 on ClinicalTrials.gov